Jefferies finds AI drives up to 50% cost cuts in drug development Jun 2, 2026 12:32PM
FDA issues draft guidance to reduce animal testing for cancer drugs May 29, 2026 09:53AM
CLSA Upgrades Charles River Labs (CRL) to Outperform (2) May 29, 2026 04:13AM
Charles River deploys AI-powered digital pathology workflow May 11, 2026 08:00AM
Charles River deploys AI-powered digital pathology workflow May 11, 2026 08:00AM
View Older Stories

May 8, 2026 04:53AM Charles River Labs (CRL) PT Raised to $192 at Mizuho
May 7, 2026 07:05AM Charles River Laboratories (CRL) Tops Q1 EPS by 12c, provides guidance
Apr 28, 2026 09:18AM Barclays: Life science insiders sold $187M in stock during first quarter
Apr 13, 2026 05:12PM RBC Capital Starts Charles River Labs (CRL) at Outperform, $215 PT
Apr 8, 2026 09:43AM Evercore Adjusts TAP Lists
Feb 25, 2026 07:01AM Charles River Labs to divest CDMO and European discovery assets
Feb 18, 2026 07:02AM Charles River Laboratories (CRL) Tops Q4 EPS by 4c ; Offers Guidance
Feb 18, 2026 07:01AM Charles River names Glenn Coleman as CFO, Kerry Dailey as CLO
Jan 21, 2026 08:03AM Charles River partners with Gazi University for rare disease therapy
Jan 12, 2026 04:30PM Charles River to acquire two companies for $570 million total
Dec 15, 2025 06:45AM BofA Securities Upgrades Charles River Labs (CRL) to Buy
Dec 1, 2025 04:16PM Morgan Stanley Assumes Charles River Labs (CRL) at Equalweight
Nov 21, 2025 02:07PM Charles River Laboratories (CRL) on Watch: CDC to end all monkey research - Science.org
Nov 17, 2025 08:19AM Charles River Laboratories SEC probe ends with no enforcement action
Nov 10, 2025 04:57AM Charles River Labs (CRL) PT Lowered to $197 at TD Cowen
Nov 6, 2025 02:21AM Baird Upgrades Charles River Labs (CRL) to Outperform
Nov 5, 2025 07:18AM Charles River Laboratories (CRL) Tops Q3 EPS by 9c ; Offers Guidance
Nov 5, 2025 07:01AM Charles River Labs plans divestitures, cost cuts following review
Oct 13, 2025 09:50AM TD Cowen Reiterates Buy Rating on Charles River Labs (CRL), lifts PT
Oct 6, 2025 06:01AM William Blair Upgrades Charles River Labs (CRL) to Outperform
Oct 2, 2025 06:10AM Barclays Upgrades Charles River Labs (CRL) to Overweight
Sep 9, 2025 03:09AM Jefferies Upgrades Charles River Labs (CRL) to Buy
Aug 6, 2025 01:59PM Charles River Labs (CRL) PT Raised to $175 at BofA Securities
Aug 6, 2025 07:03AM Charles River Laboratories (CRL) Tops Q2 EPS by 62c, Beats on Revenue; Offers FY25 EPS Guidance
Jul 31, 2025 08:04AM Charles River explores crowdfunding partnership with BioTech Social
Jul 14, 2025 04:02PM CFRA Downgrades Charles River Labs (CRL) to Hold
Jul 9, 2025 05:04AM Citi Upgrades Charles River Labs (CRL) to Buy
May 28, 2025 08:04AM Charles River Laboratories (CRL) and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
May 23, 2025 03:55AM Redburn-Atlantic Upgrades Charles River Labs (CRL) to Buy
May 7, 2025 11:34PM Charles River Labs (CRL) PT Raised to $180 at Deutsche Bank
May 7, 2025 11:28PM Evercore ISI Upgrades Charles River Labs (CRL) to Outperform
May 7, 2025 03:56PM Charles River to initiate a review amid Elliott stake - Is a sale next?
May 7, 2025 07:06AM Charles River Laboratories (CRL) Tops Q1 EPS by 25c; raises guidance
May 7, 2025 07:01AM Charles River Laboratories (CRL) Announces Governance Updates and Strategic Review to Enhance Long-Term Stockholder Value
May 6, 2025 09:56AM Charles River Laboratories (CRL) on watch on chatter
Apr 11, 2025 05:55AM Charles River Laboratories (CRL) options active into FDA reducing animal testing
Mar 21, 2025 04:30AM Goldman Sachs Downgrades Charles River Labs (CRL) to Neutral
Mar 20, 2025 10:38AM Jefferies Reiterates Hold Rating on Charles River Labs (CRL)
Mar 4, 2025 05:05AM Citi Upgrades Charles River Labs (CRL) to Neutral
Mar 3, 2025 03:24AM Redburn-Atlantic Upgrades Charles River Labs (CRL) to Neutral
Feb 25, 2025 08:01AM Charles River Laboratories (CRL) Announces Agreement with Singapore General Hospital
Feb 19, 2025 12:33PM Charles River Labs (CRL) PT Lowered to $175 at Evercore ISI
Feb 19, 2025 07:01AM Charles River Laboratories (CRL) Tops Q4 EPS by 12c ; Offers Guidance
Jan 22, 2025 06:56AM William Blair Downgrades Charles River Labs (CRL) to Market Perform
Jan 21, 2025 10:33AM Charles River Labs (CRL) PT Lowered to $182 at TD Cowen
Jan 17, 2025 04:19AM UBS Downgrades Charles River Labs (CRL) to Neutral
Jan 15, 2025 05:16AM Charles River Labs (CRL) PT Lowered to $169 at Jefferies
Jan 14, 2025 09:39AM Citi Reiterates Sell Rating on Charles River Labs (CRL)
Jan 14, 2025 09:37AM JPMorgan Reiterates Neutral Rating on Charles River Labs (CRL)
Jan 14, 2025 09:35AM TD Cowen Reiterates Hold Rating on Charles River Labs (CRL)
View Older Stories